from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3521/-

LFCtreatmentdescriptionclass of inhibitor

0.658

Amikacinug/mL Amikacintranslation

1.383

Cap5-10ug/mL Capreomycintranslation

1.589

Rox10-50 ug/mL Roxithromycintranslation

0.972

SM2-5 ug/mL Streptomycintranslation

1.265

Tet5-10 ug/mL Tetracyclinetranslation

-0.482

Rif0.2-5ug/mL Rifampicintranscription

0.092

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.031

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.063

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.592

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.075

Clofazimine10-13 ug/mL Clofaziminerespiration

0.082

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.841

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.057

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.831

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.113

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.259

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.115

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.286

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.306

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.737

KCN5-20 ug/mL Potassium cyaniderespiration

-0.405

NaN30.2-2 mM Sodium aziderespiration

0.903

Nigericin50 uM Nigericinrespiration

-0.380

TRC10-150 ug/mL Triclosanrespiration

-0.701

TRZ10-25 ug/mL Thioridazinerespiration

2.862

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.258

menadione6-10 ug/mL Menadionerespiration

2.185

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.197

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.579

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.599

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.291

NRP_1Non-replicating persistence stage 1dosRassociated

0.276

Amp0.2mg/mL AmpicillincellWall

0.017

Cephalexin20-100 ug/mL CephalexincellWall

-0.022

Cerulenin0.32-5 ug/mL CerulenincellWall

0.260

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.075

EMB10-20 ug/mL EthambutolcellWall

0.010

Eta12-40 ug/mL EthionamidecellWall

-0.487

INH0.2-0.4 ug/mL IsoniazidcellWall

0.055

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.040

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.836

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.373

BZA0.12 mg/mL BenzamidearomaticAmides

-0.615

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.336

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.548

H2O24 mM hydrogen peroxideDNAdamaging

0.265

Levo10 ug/mL LevofloxacinDNAdamaging

-0.365

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.980

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.620

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.240

UVUV-irradiationDNAdamaging

-0.412

ARP41-4 ug/mL Antitubercular compound ARP4?

0.723

Antimycin12.5-50 ug/mL Antimycin A?

0.838

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.032

PA_110-50 ug/mL Antitubercular compound PA-1?

0.103

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.862

PA8240.2-2 ug/mL PA-824?

-0.895

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.691

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.720

Verapamil50 uM Verapamil?

0.244

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.352

methoxatin10-20 ug/mL Methoxatin?